Visit our exhibition network
April 9–12, 2024 Munich
November 18–20, 2024 Shanghai
April 15–17, 2024 Mumbai
April 2–4, 2025 Ho Chi Minh City
July 8–10, 2025 Johannesburg
Our next fair
analytica has been the world’s leading trade fair for laboratory technology, analysis and biotechnology for five decades.
April 9–12, 2024
Munich
Selected departments
Selected industries
Most read white papers
From now on, don't miss a thing: Our newsletter for analytics and lab technology brings you up to date every Tuesday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Note
The function "Store search" is only available to registered users.
Important information
Currently, you are not logged in to my.analytica-world.com. Therefore, you can remember a maximum of 5 contents.
FILTER
Refine your search with the following facets to narrow down your results.
18-Dec-2007 - OncoMethylome Sciences entered into a pharmacogenomic service collaboration with Abbott. Under the terms of the collaboration, OncoMethylome will assist Abbott in profiling tumors. Specifically, OncoMethylome will be testing its DNA methylation biomarkers on Abbott's biological samples. "We are ...
08-Sep-2006 - Agilent Technologies Inc. announced it has obtained worldwide, non-exclusive patent licenses from Abbott Molecular Inc. for the manufacture, marketing and sale of oligonucleotide microarrays using a two-or-more color technology for gene expression and comparative genomic hybridization (CGH) ...
05-Sep-2006 - On Friday, September 1, 2006, a Jury unanimously upheld the validity of Innogenetics' patent, U.S. Patent No. 5,846,704 ("the '704 patent"), which claims a method of genotyping the Hepatitis C Virus ("HCV"). The dispute began in September 2005 when Innogenetics brought suit against Abbott ...
25-Jan-2006 - Abbott announced that a highly sensitive new test for the simultaneous detection of the sexually transmitted pathogens Chlamydia trachomatis (CT) and Neissera gonorrhoeae (NG) has received CE Mark certification, allowing it to be marketed in the European Union. The test is designed for use on the ...
Celera Genomics to Partner or Sell Small Molecule Drug Development Programs
11-Jan-2006 - Applera Corporation announced that its Board of Directors has approved a restructuring of its Celera Diagnostics joint venture, whereby, effective January 1, 2006, Celera Genomics acquired Applied Biosystems' 50 percent interest in the joint venture in exchange for a package of considerations to ...
19-Apr-2005 - Celera Genomics Group, an Applera Corporation business, and Abbott announced that two Celera antigen targets have been selected for further investigation by Abbott for therapeutic development. These are the first targets to be selected for advancement in the strategic collaboration established ...
04-Mar-2005 - Abbott announced that it has entered into an agreement with Inpeco S.p.A. to expand its laboratory automation capabilities. Through the agreement, Abbott plans to offer a suite of automation solutions that can be customized to address key needs within the laboratory, enhancing the consistency and ...
© 1997-2024 LUMITOS AG, All rights reserved